EnWave Appoints New Independent Director

VANCOUVER, BRITISH COLUMBIA--(Marketwired - Nov. 26, 2013) - EnWave Corporation (TSX VENTURE:ENW)(FRANKFURT:E4U) ("EnWave", or the "Company") announced today that it has appointed Dr. Stewart Ritchie as a Non-Executive Independent Director to join the six current Directors sitting on EnWave's Board. Dr. Stewart Ritchie, a Veterinarian by trade, is the President of Canadian Poultry Consultants and S.J. Ritchie Research Farms. He also is the past president of the American Association of Avian Pathologists.

Dr. Ritchie developed and has been participating in the Platinum Brooding^® program since inception. The Platinum Brooding^® program is an educational session used by poultry producers to promote poultry health and is now part of the curriculum at the University of Georgia, Master of Avian Medicine program and the Aviagen International Broiler Production School in Alabama. The Platinum Brooding^® program is also now part of the New Producer Entrant program of the British Columbia Broiler Chicken Marketing Board. Furthermore, Stewart was the founder of the Western Meeting of Poultry Clinicians and Pathologists in 1990 and is a member and has participated in numerous poultry production and scientific sessions throughout the globe.

Dr. Ritchie received his B.Sc. in Agriculture from the University of British Columbia, earned his M.S. from the University of Arkansas and D.V.M. from the University of Saskatchewan. Stewart is also a Diplomate in the American College of Poultry Veterinarians.

"Stew has been a leader in his field for multiple decades and he has an extensive network in the animal health and feed industries," stated Dr. Tim Durance, Chairman and Co-CEO of EnWave. "More specifically, he has many strong contacts in companies that are currently producing enzymes, animal vaccines and feed products."

"I am intrigued by the potential of EnWave's Radiant Energy Vacuum technology," stated Dr. Stewart Ritchie, President of Canadian Poultry Consultants. "I look forward to working with the Board to ensure that all Company efforts are in the best interest of maximizing shareholder value."

About EnWave

EnWave Corporation is a Vancouver-based industrial technology company developing commercial applications for its proprietary Radiant Energy Vacuum (REV™) dehydration technology. EnWave aims to sign royalty-bearing commercial licenses with leading food and pharmaceutical companies for the use of its revolutionary technology. Thus far the Company has signed commercial licenses with Bonduelle, a global leader in the production of vegetables, for the processing of dehydrofrozen vegetables; Hormel Foods Corporation, a major processed meat manufacturer, for the production of healthy dried meat products; Milne Fruit Product, EnWave's first major licensee, for the production of several dehydrated fruit and vegetable products in the whole, fragmented and powdered form; a leading North American enzyme company, to dehydrate a series of food-related enzymes for their Tier 1 clients; and Napa Mountain Spice Company, to dry high-quality California bay leaves. In addition to these licenses, EnWave has formed a Limited Liability Partnership with Lucid Capital Management to develop, manufacture, market and sell all-natural cheese snack products in the United States under the Moon Cheese^® brand.

Also, EnWave has entered into a wide range of research and collaboration agreements with an expanding list of multinational companies, including Nestlé, Kellogg's, Grupo Bimbo, Grimmway Farms, Ocean Spray Cranberries, Cherry Central, Sun-Maid Growers, Gay Lea Foods and Merck. EnWave is introducing REV™ as a new dehydration standard in the food and biological material sectors: potentially faster and cheaper than freeze drying, with better end product quality than air drying or spray drying.

EnWave currently has six REV™ platforms: commercial-scale nutraREV^® and MIVAP^® are used in the food industry to dry fruits, vegetables, meat, herbs and seafood quickly and at low-cost, while maintaining high levels of nutrition, taste, texture and colour. The Company is also developing powderREV™ for bulk dehydration of food cultures, probiotics and fine biochemicals such as enzymes; quantaREV™ for continuous, high-volume low-temperature drying of pastes, gels, liquids, or particulates; and bioREV™ and freezeREV™ as new methods to stabilize and dehydrate biopharmaceuticals such as vaccines and antibodies. More information about EnWave is available at www.enwave.net.

EnWave Corporation

Dr. Tim Durance, Chairman & Co-CEO

Safe Harbour for Forward-Looking Information Statements: This press release may contain forward-looking information based on management's expectations, estimates and projections. All statements that address expectations or projections about the future, including statements about the Company's strategy for growth, product development, market position, expected expenditures, and the expected synergies following the closing are forward-looking statements. All third party references to market information in this release are not guaranteed to be accurate as the Company did not conduct the original primary research. These statements are not a guarantee of future performance and involve a number of risks, uncertainties and assumptions. Although the Company has attempted to identify important factors that could cause actual results to differ materially, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.